文献速递神经MR

非增强定量MRI检测钆增强多发性硬化脑病灶的系统评价与Meta分析

The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-05-18

该系统评价与Meta分析纳入37篇文献共985例多发性硬化患者,比较增强与非增强病灶的ROI定量MRI指标。DTI来源的各向异性分数在增强与非增强病灶间有显著差异(P=0.02),增强病灶FA降低;平均弥散率、磁化传递率、ADC均无显著差异。基于梯度回波的定量磁化率图在区分增强与非增强病灶方面表现最佳。

要点

  • DTI来源的FA在增强与非增强MS病灶间有显著差异(P=0.02),增强病灶FA降低。
  • 平均弥散率、磁化传递率、ADC在增强与非增强病灶间均无显著差异。
  • 基于梯度回波的定量磁化率图在区分增强与非增强MS病灶方面表现最佳。

核心结论

  • 非增强MR成像技术如DTI来源的FA可在不使用钆对比剂的情况下评估MS病灶的急性程度。

研究设计与样本

  • 系统评价与Meta分析,纳入37篇期刊文献共985例多发性硬化患者,检索Ovid MEDLINE、Ovid Embase和Cochrane数据库自建库至2016年8月,纳入在同一MR检查中T1加权增强后序列与非增强序列通过ROI分析比较单个MS病灶的研究。

关键影像表现/征象

  • DTI来源的各向异性分数在增强与非增强病灶间有显著差异(P=0.02),增强病灶FA较非增强病灶降低。
  • 平均弥散率在增强与非增强病灶间无显著差异(P=0.30)。
  • 磁化传递率在增强与非增强病灶间无显著差异(P=0.47)。
  • ADC在增强与非增强病灶间无显著差异(P=0.19)。

诊断标准与关键数值

  • DTI来源的FA在增强与非增强病灶间有显著差异(P=0.02)。
  • 平均弥散率在增强与非增强病灶间无显著差异(P=0.30)。
  • 磁化传递率在增强与非增强病灶间无显著差异(P=0.47)。
  • ADC在增强与非增强病灶间无显著差异(P=0.19)。
  • 提供诊断准确性指标的研究有限,其中基于梯度回波的定量磁化率图在区分增强与非增强MS病灶方面表现最佳。

局限性

  • 各研究的MR成像技术和患者特征存在差异。
  • 大多数研究未提供诊断准确性指标。
  • 并非所有37项研究均评估了所有影像指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Concerns have arisen about the long-term health effects of repeat gadolinium injections in patients with multiple sclerosis and the incomplete characterization of MS lesion pathophysiology that results from relying on enhancement characteristics alone.

PURPOSE: Our aim was to perform a systematic review and meta-analysis analyzing whether noncontrast MR imaging biomarkers can distinguish enhancing and nonenhancing brain MS lesions.

DATA SOURCES: Our sources were Ovid MEDLINE, Ovid Embase, and the Cochrane data base from inception to August 2016.

STUDY SELECTION: We included 37 journal articles on 985 patients with MS who had MR imaging in which T1-weighted postcontrast sequences were compared with noncontrast sequences obtained during the same MR imaging examination by using ROI analysis of individual MS lesions.

DATA ANALYSIS: We performed random-effects meta-analyses comparing the standard mean difference of each MR imaging metric taken from enhancing-versus-nonenhancing lesions.

DATA SYNTHESIS: DTI-based fractional anisotropy values are significantly different between enhancing and nonenhancing lesions (P = .02), with enhancing lesions showing decreased fractional anisotropy compared with nonenhancing lesions. Of the other most frequently studied MR imaging biomarkers (mean diffusivity, magnetization transfer ratio, or ADC), none were significantly different (P values of 0.30, 0.47, and 0.19. respectively) between enhancing and nonenhancing lesions. Of the limited studies providing diagnostic accuracy measures, gradient-echo-based quantitative susceptibility mapping had the best performance in discriminating enhancing and nonenhancing MS lesions.

LIMITATIONS: MR imaging techniques and patient characteristics were variable across studies. Most studies did not provide diagnostic accuracy measures. All imaging metrics were not studied in all 37 studies.

CONCLUSIONS: Noncontrast MR imaging techniques, such as DTI-based FA, can assess MS lesion acuity without gadolinium.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Gupta A, Al-Dasuqi K, Xia F, et al. The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2017. PMID: 28522663. doi:10.3174/ajnr.A5209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。